SAN FRANCISCO , Nov. 11, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al.

image for news MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

SoftBank Group's $5.8 billion sale of its Nvidia stake jolted stock markets on Tuesday, stoking fears that the frenzy around artificial intelligence may have peaked, especially after recent warnings from Wall Street bank chiefs and a famed short seller.

image for news SoftBank's $5.8 billion Nvidia stake sale stirs fresh AI bubble fears

FCPT Boosts Portfolio With Strategic Veterinary Real Estate Purchase — Positive

FCPT   Zacks Investment Research — November 11, 2025

Four Corners Property expands with a $13.8M veterinary clinic portfolio, reinforcing its diversification strategy amid market uncertainty.

image for news FCPT Boosts Portfolio With Strategic Veterinary Real Estate Purchase

Ondas Holdings to Report Q3 Earnings: How to Approach the Stock Now? — Positive

ONDS   Zacks Investment Research — November 11, 2025

ONDS' OAS momentum, defense partnerships and strong backlog set the stage ahead of its third-quarter earnings release.

image for news Ondas Holdings to Report Q3 Earnings: How to Approach the Stock Now?

HealthStream Announces Share Repurchase Program — Neutral

HSTM   Business Wire — November 11, 2025

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, today announced that its Board of Directors has approved a new share repurchase program for the Company's common stock, under which the Company may repurchase up to $10 million of outstanding shares of common stock. Pursuant to the authorization, repurchases may be made from time to time in the open market, including under a Rule 10b5-1 plan, through privatel.

image for news HealthStream Announces Share Repurchase Program

BigBear.ai: Q3 Beat Expectations, Yet The Real Test Is Still Ahead — Positive

BBAI   Seeking Alpha — November 11, 2025

BigBear.ai (BBAI) operates in the promising AI defense sector but current financials do not justify its $2.5B+ market cap (at least yet). Q3 earnings beat estimates, and the Ask Sage acquisition adds ARR potential, yet revenue remains low and margins are compressed. BBAI's valuation is still a little speculative; future growth hinges on securing large, multi-year government contracts and improving operational leverage.

image for news BigBear.ai: Q3 Beat Expectations, Yet The Real Test Is Still Ahead

ATYR Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Nov. 11, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The firm urges investors in aTyr who suffered significant losses to submit your losses now.

image for news aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

Microsoft: Why You'll Regret Selling Now (It's Not What You Think) — Positive

MSFT   Seeking Alpha — November 11, 2025

Microsoft Corporation delivered strong Q1 FY' 26 results, with revenue and EPS surpassing estimates, yet shares fell ~7% post-earnings. MSFT's cloud and AI infrastructure demand remains robust, driving significant capital investment and positioning the company for accelerated growth in coming quarters. The strategic OpenAI partnership and major government AI adoption initiatives provide long-term growth catalysts and reinforce Azure's competitive edge.

image for news Microsoft: Why You'll Regret Selling Now (It's Not What You Think)

Gold Price Outlook – Gold Grinds Higher Early on Tuesday — Negative

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   FXEmpire — November 11, 2025

Gold extended its rally on Tuesday, but momentum slowed compared to Monday. The analyst highlights key resistance at $4,150–$4,200, suggesting a potential short-term pullback unless prices break higher.

image for news Gold Price Outlook – Gold Grinds Higher Early on Tuesday

Atai Beckley N.V. ( ATAI ) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression November 10, 2025 8:00 AM EST Company Participants Ashleigh Barreto Srinivas Rao - Co-Founder, CEO & Executive Director Kevin Craig - Chief Medical Officer Robert Conley - Chief Research & Development Officer Conference Call Participants Lin Tsai - Jefferies LLC, Research Division Ritu Baral - TD Cowen, Research Division Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division Harry Gillis - Joh.

image for news Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript

Pembina Pipeline Q3 Earnings & Revenues Miss Estimates, Both Down Y/Y — Negative

PBA   Zacks Investment Research — November 11, 2025

PBA expects 2025 adjusted EBITDA in the range of C$4.25 billion to C$4.35 billion compared with the previous guidance of C$4.23 billion to C$4.43 billion.

image for news Pembina Pipeline Q3 Earnings & Revenues Miss Estimates, Both Down Y/Y

Buy 5 Business Services Sector Stocks to Boost Your Portfolio Stability — Positive

OMC  TRI  ULS  VLTO  XYL   Zacks Investment Research — November 11, 2025

These five Business Services stocks, XYL, TRI, ULS, OMC and VLTO, offer growth and stability amid strong sector fundamentals.

image for news Buy 5 Business Services Sector Stocks to Boost Your Portfolio Stability

Will Data Center AI Chip Demand Keep Aiding Micron's Sales Growth? — Positive

MU   Zacks Investment Research — November 11, 2025

Surging data center demand, powered by AI-driven memory and storage solutions, positions MU for another year of robust revenue growth.

image for news Will Data Center AI Chip Demand Keep Aiding Micron's Sales Growth?

Crude Oil Price Outlook – Oil Continues to Consolidate — Neutral

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   FXEmpire — November 11, 2025

Oil attempted to rally on Tuesday after dipping below $60, but resistance between $60 and $62 remains firm. The analyst sees crude trading sideways amid persistent oversupply from the U.S., OPEC, and Russia.

image for news Crude Oil Price Outlook – Oil Continues to Consolidate

Lead Plaintiff Deadline is January 2, 2026 NEW YORK , Nov. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against CarMax, Inc. ("CarMax" or the "Company") (NYSE: KMX) and certain of its officers for alleged violations of federal securities laws. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period: June 20, 2025 – September 24, 2025 (inclusive) Key Events: CarMax and certain executives allegedly violated the Securities Exchange Act of 1934.

image for news Shareholders who lost money in shares of CarMax, Inc. (NASDAQ: KMX) Should Contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline is December 2, 2025 NEW YORK , Nov. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) ("Molina") securities between February 5, 2025 and July 23, 2025 (the "Class Period") have until December 2, 2025 to seek appointment as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The filed complaint alleges that Molina Healthcare and certain executives violated the Securities Exchange Act of 1934 by making materially false and misleading statements about the company's financial outlook and medical cost trends.

image for news Shareholders who lost money in shares of Molina Healthcare, Inc. (NYSE: MOH) Should Contact Wolf Haldenstein Immediately

New York, New York--(Newsfile Corp. - November 11, 2025) - If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ: RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=176749&wire=5&utm_campaign=7 or contact Joseph E. Levi, Esq.

image for news RICK LAWSUIT ALERT: Levi & Korsinsky Notifies RCI Hospitality Holdings, Inc. Investors - Lead Plaintiff Deadline November 20, 2025

HOUSTON , Nov. 11, 2025 /PRNewswire/ -- Salarius Pharmaceuticals, Inc. ("Salarius" or the "Company") (NASDAQ: SLRX) today announced the pricing of an underwritten public offering for gross proceeds of approximately $7 million before deducting underwriting discounts and commissions and other offering expenses. The offering is comprised of 2,514,335 shares of its common stock ("Common Stock") and pre-funded warrants to purchase 2,152,331 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to an aggregate of 4,666,666 shares of Common Stock and Series B Warrants to purchase up to an aggregate of 4,666,666 shares of Common …

image for news Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering

Lead Plaintiff Deadline is December 26, 2025 NEW YORK , Nov. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period: July 26, 2024 – September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design …

image for news Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

Beyond Meat posts bigger Q3 loss, outlook disappoints — Negative

BYND   Proactive Investors — November 11, 2025

Beyond Meat Inc (NASDAQ:BYND) late Monday reported third quarter 2025 earnings that fell short of analyst expectations and issued weaker than expected Q4 sales guidance. The provider of plant-based meat products recorded an adjusted loss per share in Q3 of $0.47, missing the Wall Street forecast, which was for a deficit of $0.45 per share.

image for news Beyond Meat posts bigger Q3 loss, outlook disappoints